The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multi-institutional analysis of outcomes in patients with dedifferentiated chondrosarcoma (DDCS).
 
Nam Bui
No Relationships to Disclose
 
Hilary Dietz
No Relationships to Disclose
 
Angela C. Hirbe
No Relationships to Disclose
 
Kristen N. Ganjoo
Consulting or Advisory Role - Daiichi Sankyo; Immune Design; Janssen; Lilly; Novartis
 
Brian Andrew Van Tine
Consulting or Advisory Role - Caris Life Sciences; CytRx Corporation; EMD Serono; Johnson & Johnson; Lilly/ImClone; Novartis; Plexxikon; Threshold Pharmaceuticals
Speakers' Bureau - Caris Life Sciences; Johnson & Johnson; Lilly; Novartis
Research Funding - Merck; Pfizer
Expert Testimony - Me1 Patient
 
Vicki Leigh Keedy
Consulting or Advisory Role - Karyopharm Therapeutics
Research Funding - Advenchen Laboratories (Inst); BioMed Valley Discoveries (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Lilly (Inst); medpacto (Inst); Plexxikon (Inst); Roche (Inst); TRACON Pharma (Inst)
 
Elizabeth J. Davis
Research Funding - Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst)